Furthermore, molecular alterations characteristically seen in ICC, such as changes in PBRM1, IDH1, IDH2, FGFR2, and BAP1 were not present across cHCC-ICC (44, 47, 51). This evidence concerns the gene BAP1 and intrahepatic cholangiocarcinoma.